PILL.CN - Canntab Therapeutics Limited

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 511.64M
Enterprise Value 310.01M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)34.15
Price/Book (mrq)9.02
Enterprise Value/Revenue 329.36
Enterprise Value/EBITDA 6-5.13

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-48.68%
S&P500 52-Week Change 3-14.06%
52 Week High 30.9500
52 Week Low 30.2700
50-Day Moving Average 30.4600
200-Day Moving Average 30.4823

Share Statistics

Avg Vol (3 month) 317.07k
Avg Vol (10 day) 38.34k
Shares Outstanding 525.31M
Float 25.24M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Mar. 12, 2020) 410.32k
Short Ratio (Mar. 12, 2020) 40.47
Short % of Float (Mar. 12, 2020) 4N/A
Short % of Shares Outstanding (Mar. 12, 2020) 40.04%
Shares Short (prior month Feb. 13, 2020) 4500

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar. 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr. 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2019
Most Recent Quarter (mrq)Nov. 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-602.47%

Management Effectiveness

Return on Assets (ttm)-44.94%
Return on Equity (ttm)-99.52%

Income Statement

Revenue (ttm)340.83k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)143.61k
Net Income Avi to Common (ttm)-2.29M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)182.84k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)319.91k
Total Debt/Equity (mrq)25.01
Current Ratio (mrq)1.08
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-2M
Levered Free Cash Flow (ttm)-1.58M